International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 2 , Pages 377-385 , 1 June 2008

Patterns of Failure and Toxicity after Intensity-Modulated Radiotherapy for Head and Neck Cancer

Received 21 August 2007 ,Revised 9 October 2007 ,Accepted 12 October 2007.

References 

  1. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol. 2006;24:2618–2623
  2. Liauw SL, Mancuso AA, Amdur RJ, et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: The use of computed tomography to manage the neck. J Clin Oncol. 2006;24:1421–1427
  3. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  4. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  5. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28–42
  6. Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312–321
  7. Thorstad W, Hong S, Hope AJ, et al. Patterns of failure in patients receiving intensity-modulated radiation therapy (IMRT) for head and neck cancer. [Abstract] Int J Radiat Oncol Biol Phys. 2005;36:S74
  8. Pacholke HD, Amdur RJ, Morris CG, et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol. 2005;28:351–358
  9. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695–704
  10. Eisbruch A, Rhodus N, Rosenthal D, et al. How should we measure and report radiotherapy-induced xerostomia?. Semin Radiat Oncol. 2003;13:226–234
  11. Lin A, Kim HM, Terrell JE, et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57:61–70
  12. Fein DA, Lee WR, Amos WR, et al. Oropharyngeal carcinoma treated with radiotherapy: A 30-year experience. Int J Radiat Oncol Biol Phys. 1996;34:289–296
  13. Mendenhall WM, Morris CG, Amdur RJ, et al. Parameters that predict local control following definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2003;25:535–542
  14. Mendenhall WM, Morris CG, Amdur RJ, et al. Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol. 2006;29:32–39
  15. Mendenhall WM, Morris CG, Hinerman RW, et al. Definitive radiotherapy for nasopharyngeal carcinoma. Am J Clin Oncol. 2006;29:622–627
  16. Huang K, Lee N, Xia P, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal carcinoma: A single institutional experience. [Abstract] Int J Radiat Oncol Biol Phys. 2003;57:S302
  17. de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2006;64:363–373
  18. Yao M, Dornfeld KJ, Buatti JM, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma–the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2005;63:410–521
  19. Lee N, Xia P, Fischbein NJ, et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49–60
  20. Mendenhall WM, Morris CG, Amdur RJ, et al. Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol. 2006;29:290–297
  21. Garden AS, Morrison WH, Rosenthal DI, et al. Intensity modulated radiation therapy (IMRT) for metastatic cervical adenopathy from oropharynx carcinoma. [Abstract] Int J Radiat Oncol Biol Phys. 2004;60:S318

 Conflict of interest: none.

PII: S0360-3016(07)04423-9

doi: 10.1016/j.ijrobp.2007.10.010

International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 2 , Pages 377-385 , 1 June 2008